Ynno Med Limited
June 16, 2025
Company Presentation
Infectious Disease and Vaccines
153B
Ynno Med is a drug R&D company committed to addressing the unmet clinical needs for new antimicrobial agents to combat antimicrobial resistance. Our goal is to design, develop, and distribute first-in-class (FIC) antimicrobial medicines that effectively treat current antibiotic-resistant bacterial infections and suppress the emergence of new resistance. We accelerate our drug development process using our in-house AI-driven drug optimization platform, which is also available for providing drug design and discovery services.
Company HQ City:
Hong Kong
Company HQ Country:
Hong Kong
Year Founded:
2021
Lead Product in Development:
2-3
CEO
Cong Ma
Development Phase of Lead Product
Pre-Clinical
When you expect your next catalyst update?
IND
What is your next catalyst (value inflection) update?
1-2 years
Website
https://www.ynnomed.com/
)
)
){kind=logo}
){kind=logo}
){kind=logo}